# FDA Inspection 1245618 - Medpace Inc - July 11, 2024

Source: https://www.keypedia.com/records/fda_inspections/medpace-inc/73fc50bb-105c-4d98-afdf-261bcc8d5f20
Source feed: FDA_Inspections

> FDA Inspection 1245618 for Medpace Inc on July 11, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1245618
- Company Name: Medpace Inc
- Inspection Date: 2024-07-11
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1263213 - 2025-02-13](https://www.keypedia.com/records/fda_inspections/medpace-inc/f38db091-2a1f-4f90-a4f0-b50a71d98578)
- [FDA Inspection 1263213 - 2025-02-13](https://www.keypedia.com/records/fda_inspections/medpace-inc/a80bcb9d-8637-4ed0-a313-adb4a0a20094)
- [FDA Inspection 1232744 - 2024-03-06](https://www.keypedia.com/records/fda_inspections/medpace-inc/361b5eb5-bbfa-4117-ae30-7c27ba67b824)
- [FDA Inspection 1169068 - 2022-04-26](https://www.keypedia.com/records/fda_inspections/medpace-inc/f0d2d381-2bd1-45c2-9c1b-13b687f75432)
- [FDA Inspection 1145127 - 2021-05-14](https://www.keypedia.com/records/fda_inspections/medpace-inc/0b8fa074-b27f-4d82-9942-66d62ffb626e)

Company: https://www.keypedia.com/companies/medpace-inc/e09bfcb9-1613-4cc0-8434-8913be0f770d

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c